Böhm E et al. |
11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. |
2004 |
J. Biol. Chem. |
pmid:14668348
|
Suzuki N et al. |
Quantitative liquid chromatography-tandem mass spectrometric analysis of 11-dehydro TXB2 in urine. |
2004 |
Prostaglandins Other Lipid Mediat. |
pmid:15165035
|
Perneby C et al. |
Prothrombotic responses to exercise are little influenced by clopidogrel treatment. |
2004 |
Thromb. Res. |
pmid:15381386
|
Minuz P et al. |
Determinants of platelet activation in human essential hypertension. |
2004 |
Hypertension |
pmid:14656953
|
Vainio M et al. |
Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders. |
2004 |
Acta Obstet Gynecol Scand |
pmid:15548142
|
Dippel DW et al. |
What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke? |
2004 |
Cerebrovasc. Dis. |
pmid:15026612
|
Coppola A et al. |
Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype. |
2005 |
Br. J. Haematol. |
pmid:16173969
|
Kataoka M et al. |
A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension. |
2005 |
Am. J. Respir. Crit. Care Med. |
pmid:16192456
|
Gonzalez-Conejero R et al. |
Biological assessment of aspirin efficacy on healthy individuals: heterogeneous response or aspirin failure? |
2005 |
Stroke |
pmid:15604423
|
Falco A et al. |
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. |
2005 |
Atherosclerosis |
pmid:16285996
|